Colgate-Palmolive (NYSE:CL) Price Target Lowered to $97.00 at JPMorgan Chase & Co.

Colgate-Palmolive (NYSE:CL) had its price objective lowered by stock analysts at JPMorgan Chase & Co. from $103.00 to $97.00 in a note issued to investors on Monday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s target price indicates a potential upside of 12.06% from the stock’s previous close.

Other equities research analysts also recently issued reports about the stock. StockNews.com downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. Barclays lowered their target price on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research note on Friday, January 17th. Piper Sandler reduced their price target on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research report on Monday, January 6th. Morgan Stanley decreased their price target on shares of Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating on the stock in a report on Monday. Finally, Royal Bank of Canada reissued a “sector perform” rating and set a $101.00 price objective on shares of Colgate-Palmolive in a research note on Wednesday, January 29th. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Colgate-Palmolive currently has a consensus rating of “Hold” and a consensus target price of $101.16.

Colgate-Palmolive Stock Down 0.5 %

Colgate-Palmolive stock opened at $86.56 on Monday. The firm has a 50 day simple moving average of $91.19 and a 200 day simple moving average of $97.07. The company has a current ratio of 0.41, a quick ratio of 0.26 and a debt-to-equity ratio of 9.46. Colgate-Palmolive has a 1-year low of $82.68 and a 1-year high of $109.30. The firm has a market capitalization of $70.72 billion, a price-to-earnings ratio of 24.59, a P/E/G ratio of 3.61 and a beta of 0.44.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period in the previous year, the firm earned $0.87 earnings per share. On average, analysts predict that Colgate-Palmolive will post 3.74 earnings per share for the current year.

Institutional Trading of Colgate-Palmolive

Institutional investors have recently added to or reduced their stakes in the business. Centricity Wealth Management LLC bought a new stake in shares of Colgate-Palmolive in the 4th quarter valued at about $27,000. Union Bancaire Privee UBP SA purchased a new position in Colgate-Palmolive in the 4th quarter worth approximately $32,000. Hager Investment Management Services LLC bought a new stake in Colgate-Palmolive in the fourth quarter valued at approximately $36,000. Reston Wealth Management LLC purchased a new stake in shares of Colgate-Palmolive during the third quarter valued at approximately $42,000. Finally, Roxbury Financial LLC bought a new position in shares of Colgate-Palmolive in the fourth quarter worth approximately $43,000. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.